CSIMarket
 


Intercure Ltd   (INCR)
Other Ticker:  
 
 

INCR's Net Income Growth by Quarter and Year

Intercure Ltd 's Net Income results by quarter and year




INCR Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 43.75 7.29 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   43.75 7.29 0.00 0.00



INCR Net Income fourth quarter 2022 Y/Y Growth Comment
Intercure Ltd achieved in the fourth quarter 2022, above Company average Net Income surge of 500.12% year on year, to $ 43.75 millions.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Net Income growth. While Intercure Ltd ' s Net Income doubling of 500.12% ranks overall at the positon no. 153 in the fourth quarter 2022.




INCR Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December 500.12 % - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   500.12 % - - -

Financial Statements
Intercure Ltd 's fourth quarter 2022 Net Income $ 43.75 millions INCR's Income Statement
Intercure Ltd 's fourth quarter 2021 Net Income $ 7.29 millions Quarterly INCR's Income Statement
New: More INCR's historic Net Income Growth >>


INCR Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   500.12 % - - -




Net Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #11
Overall #153

Net Income Y/Y Growth Statistics
High Average Low
499.88 % 499.88 % 499.88 %
(Dec 31 2022)  
Net Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #11
Overall #153
Net Income Y/Y Growth Statistics
High Average Low
499.88 % 499.88 % 499.88 %
(Dec 31 2022)  

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Intercure Ltd 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


INCR's IV. Quarter Q/Q Net Income Comment


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


INCR's IV. Quarter Q/Q Net Income Comment


Intercure Ltd 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
12 Months Ending
0
12 Months Ending
0
Cumulative Net Income 12 Months Ending $ 43.75 $ 0.00 $ 7.29 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) 499.88 % - - - -
Year on Year Net Income Growth Overall Ranking # 83 # 0 # 0 # 0 # 0
Seqeuential Net Income Change (TTM) 499.88 % - - - -
Seq. Net Income Growth (TTM) Overall Ranking # 86 # 0 # 0 # 0 # 0




Cumulative Net Income growth Comment
With 499.88% annual Net Income growth, Intercure Ltd would report a record annual Net Income surge if the fiscal year would end on Dec 31 2022.

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 83.

Net Income TTM Q/Q Growth Statistics
High Average Low
499.88 %
499.88 %
499.88 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 7
Overall # 83

Net Income TTM Y/Y Growth Statistics
High Average Low
499.88 %
499.88 %
499.88 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 7
S&P 500 # 86
Cumulative Net Income growth Comment
With 499.88% annual Net Income growth, Intercure Ltd would report a record annual Net Income surge if the fiscal year would end on Dec 31 2022.

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 83.

Net Income TTM Q/Q Growth Statistics
High Average Low
499.88 %
499.88 %
499.88 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 7
Overall # 83

Net Income TTM Y/Y Growth Statistics
High Average Low
499.88 %
499.88 %
499.88 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 7
S&P 500 # 86




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
INCR's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for INCR's Competitors
Net Income Growth for Intercure Ltd 's Suppliers
Net Income Growth for INCR's Customers

You may also want to know
INCR's Annual Growth Rates INCR's Profitability Ratios INCR's Asset Turnover Ratio INCR's Dividend Growth
INCR's Roe INCR's Valuation Ratios INCR's Financial Strength Ratios INCR's Dividend Payout Ratio
INCR's Roa INCR's Inventory Turnover Ratio INCR's Growth Rates INCR's Dividend Comparisons



Companies with similar Net Income surge for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2022
Healthcare Services Group Inc 667.65%$ 667.648 millions
Bellicum Pharmaceuticals Inc 525.80%$ 525.800 millions
Intercure Ltd 499.88%$ 499.877 millions
Gilead Sciences Inc 334.31%$ 334.309 millions
Radnet Inc 278.29%$ 278.294 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com